Guggenheim Capital’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $987K | Sell |
9,452
-751
| -7% | -$78.4K | 0.01% | 888 |
|
|
2025
Q1 | $1.19M | Sell |
10,203
-1,403
| -12% | -$164K | 0.01% | 817 |
|
|
2024
Q4 | $982K | Sell |
11,606
-1,766
| -13% | -$149K | 0.01% | 930 |
|
|
2024
Q3 | $1.2M | Sell |
13,372
-1,615
| -11% | -$145K | 0.01% | 1010 |
|
|
2024
Q2 | $1.21M | Sell |
14,987
-2,255
| -13% | -$182K | 0.01% | 1022 |
|
|
2024
Q1 | $1.38M | Buy |
17,242
+2,362
| +16% | +$188K | 0.01% | 1044 |
|
|
2023
Q4 | $1.18M | Buy |
+14,880
| New | +$1.18M | 0.01% | 1066 |
|